blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1635832

EP1635832 - COMBINATION THERAPY FOR THE TREATMENT OF DIABETES [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  25.01.2008
Database last updated on 12.07.2024
Most recent event   Tooltip25.01.2008Withdrawal of applicationpublished on 27.02.2008  [2008/09]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
For all designated states
BANYU PHARMACEUTICAL CO., LTD.
2-3, Nihombashi Honcho 2-chome Chuo-ku
Tokyo 103-8416 / JP
[N/P]
Former [2006/12]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue Rahway
New Jersey 07065-0907 / US
For all designated states
BANYU PHARMACEUTICAL CO., LTD.
2-3, Nihombashi Honcho 2-chome Chuo-ku
Tokyo 103-8416 / JP
Inventor(s)01 / ERONDU, Ngozi, E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / FONG, Tung, M.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / MACNEIL, Douglas, J.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
04 / VAN DER PLOEG, Leonardus, H. T.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
05 / KANATANI, Akio
2-3, Nihombashi Honcho, 2-Chome
Chuo-ku, Tokyo 103-8416 / JP
 [2006/12]
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2006/48]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2006/12]Horgan, James Michael Frederic, et al
Merck & Co., Inc., Terlings Park, Eastwick Road Harlow
Essex CM20 2QR / GB
Application number, filing date04753999.402.06.2004
[2006/12]
WO2004US17291
Priority number, dateUS20030476388P06.06.2003         Original published format: US 476388 P
[2006/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004110375
Date:23.12.2004
Language:EN
[2004/52]
Type: A2 Application without search report 
No.:EP1635832
Date:22.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.2004 takes the place of the publication of the European patent application.
[2006/12]
Search report(s)International search report - published on:US12.05.2005
ClassificationIPC:A61K31/495, A61K31/505, A61K31/44, A61K31/415, A61K31/35, A61K31/34
[2006/12]
CPC:
A61K31/353 (EP,US); A61K31/4196 (EP,US); A61K31/4747 (EP,US);
A61K31/498 (EP,US); A61K45/06 (EP,US)
C-Set:
A61K31/353, A61K2300/00 (EP,US);
A61K31/4196, A61K2300/00 (US,EP);
A61K31/4747, A61K2300/00 (US,EP);
A61K31/498, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/12]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON DIABETES[2006/12]
English:COMBINATION THERAPY FOR THE TREATMENT OF DIABETES[2006/12]
French:POLYTHERAPIE PERMETTANT DE TRAITER LE DIABETE[2006/12]
Entry into regional phase09.01.2006National basic fee paid 
09.01.2006Search fee paid 
09.01.2006Designation fee(s) paid 
09.01.2006Examination fee paid 
Examination procedure23.11.2005Amendment by applicant (claims and/or description)
09.01.2006Examination requested  [2006/12]
18.01.2008Application withdrawn by applicant  [2008/09]
Fees paidRenewal fee
27.03.2006Renewal fee patent year 03
08.06.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US6140354  (DAX SCOTT L [US], et al);
 [Y]US6258837  (FUKAMI TAKEHIRO [JP], et al);
 [Y]US6699871  (EDMONDSON SCOTT D [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.